From the Journals

When adolescents visit the ED, 10% leave with an opioid


 

FROM PEDIATRICS

A little more than 10% of adolescents who visited an emergency department during 2005-2015 received an opioid prescription, although there was a small but significant decrease in prescriptions over that time, according to an analysis of two nationwide ambulatory care surveys.

Diagnoses with the highest opioid-prescribing rates, 2005-2015

For adolescents aged 13-17 years, 10.4% of ED visits were associated with a prescription for an opioid versus 1.6% among outpatient visits. There was a slight but significant decrease in the rate of opioid prescriptions in the ED setting over the study period, with an odds ratio of 0.95 (95% confidence interval, 0.92-0.97), but there was no significant change in the trend over time in the outpatient setting (OR, 1.02; 95% CI, 0.99-1.09), Joel D. Hudgins, MD, and associates reported in Pediatrics.

“Opioid prescribing in ambulatory care visits is particularly high in the ED setting and … certain diagnoses appear to be routinely treated with an opioid,” said Dr. Hudgins and associates from Boston Children’s Hospital.

The highest rates of opioid prescribing among adolescents visiting the ED involved dental disorders (60%) and acute injuries such as fractures of the clavicle (47%), ankle (38%), and metacarpals (36%). “However, when considering the total volume of opioid prescriptions dispensed [over 7.8 million during 2005-2015], certain common conditions, including abdominal pain, acute pharyngitis, urinary tract infection, and headache, contributed large numbers of prescriptions as well,” they added.

The study involved data from the National Hospital Ambulatory Medical Care Survey (hospital-based EDs) and the National Ambulatory Medical Care Survey (office-based practices), which both are conducted annually by the National Center for Health Statistics.

The senior investigator is supported by an award from the Burroughs Wellcome Fund by the Harvard-MIT Center for Regulatory Science. The authors said that they have no relevant financial relationships.

SOURCE: Hudgins JD et al. Pediatrics. 2019 June. doi: 10.1542/peds.2018-1578.

Recommended Reading

New JIA guidelines emphasize treating to target
MDedge Rheumatology
MDedge Daily News: How smartphones could battle oral cancer
MDedge Rheumatology
Can tai chi tame seniors’ risk of falls?
MDedge Rheumatology
Subcutaneous Actemra approved for systemic JIA
MDedge Rheumatology
Pregnancy registries are a valuable resource
MDedge Rheumatology
Adalimumab safety profile similar in children and adults
MDedge Rheumatology
Prenatal valproate and ADHD
MDedge Rheumatology
Conservatism spreads in prostate cancer
MDedge Rheumatology
Mediterranean diet cut Parkinson’s risk
MDedge Rheumatology
Young lupus patients need more than medications
MDedge Rheumatology